Picture of Abbisko Cayman logo

2256 Abbisko Cayman News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Abbisko Cayman Says Unit Got Regulatory Approval From Food & Drug Administration Of U.S.

Oct 25 (Reuters) - Abbisko Cayman Ltd  2256.HK :
    * UNIT GOT REGULATORY APPROVAL FROM FOOD & DRUG
ADMINISTRATION OF
U.S. TO INITIATE FIRST-IN-HUMAN PHASE I CLINICAL STUDY FOR
ABSK061

Source text for Eikon:  ID:nHKS7sfZvg 
Further company coverage:  2256.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Abbisko Cayman

See all news